Skip to main contentAll experts

MrSanford Boye

SCIENTIST

MD-PEDIATRICS

Orcid identifier0000-0002-8803-9369 (opens in a new tab)⁠
  • SCIENTIST
    MD-PEDIATRICS

GRANTS

  • GRANT
    Task Order 20 - Assessment of Candidate Vectors for AAV-mediated Delivery of OPNLW
    Atsena Therapeutics10 Apr 2026 - 30 Sep 2026
    Active
  • GRANT
    Task Order 21 - Assessment of Candidate Vectors for AAV-mediated Delivery of PDE6B
    Atsena Therapeutics10 Apr 2026 - 15 Feb 2027
    Active
  • GRANT
    Establishment and characterization of Rd9 mouse model of RPGR-associated Retinitis Pigmentosa
    Atsena Therapeutics1 Mar 2026 - 30 Sep 2026
    Active
  • GRANT
    Breeding and transfer of Myo7a KO mice
    Atsena Therapeutics22 Feb 2026 - 30 Jun 2026
    Expired
  • GRANT
    KIZ-Mutated RP Mouse Model Characterization
    Kizuna Foundation2 Feb 2026 - 31 Oct 2027
    Active
  • GRANT
    Characterization of ocular phenotype of the YG8-800 mouse model of FA and retinal-targeted treatment by AAV based CRISPR-Cas9 gene editing
    Friedreichs Ataxia Research Alliance5 Mar 2025 - 28 Feb 2027
    Active
  • GRANT
    Development of a New Gene Therapy for Autosomal Dominant Retinitis Pigmentosa
    Foundation for Fighting Blindness1 Jan 2025 - 31 Dec 2026
    Active
  • GRANT
    Engineering AAV for safe and efficient gene delivery to the human retina
    National Institute of Health Nei5 Sep 2024 - 30 Jun 2029
    Active
  • GRANT
    PDE6A Gene Therapy Agreement
    Stiftung Für Medizininnovationen20 Aug 2024 - 19 Aug 2027
    Active
  • GRANT
    Natural history and AAV-mediated interventions for dominant negative and haploinsufficient mouse models of PRPH2-associated disease
    Foundation for Fighting Blindness1 Apr 2024 - 31 Mar 2027
    Active
  • GRANT
    Nonhuman Primate Model of Inherited Photoreceptor Degeneration
    National Institute of Health Nei5 Feb 2024 - 31 Mar 2026
    Expired
  • GRANT
    Creation of a Translational Nonhuman Primate Model of Usher Syndrome 1B
    Foundation for Fighting Blindness6 Nov 2023 - 31 Mar 2026
    Expired
  • GRANT
    AAV-Mediated Therapy for Visual Impairment associated with Friedreich’s Ataxia
    Friedreichs Ataxia Research Alliance30 Aug 2023 - 31 Aug 2025
    Expired
  • GRANT
    Maintenance of RS1 Mouse Model#
    Atsena Therapeutics13 Feb 2023 - 30 Jun 2027
    Active
  • GRANT
    Characterization and mitigation of AAV-induced ocular inflamation
    Foundation for Fighting Blindness10 Feb 2023 - 31 Mar 2026
    Expired
  • GRANT
    Task Order #13- ‘Development of AAV Candidates for the Treatment of Ocular Friedrich’s Ataxia’
    Atsena Therapeutics27 Sep 2022 - 10 Jul 2023
    Expired
  • GRANT
    Assessment of Candidate Vectors for AAV-mediated Delivery of ABCA4
    Atsena Therapeutics15 Apr 2022 - 28 Feb 2027
    Active
  • GRANT
    Propagation of a Nonhuman Primate Model of Usher Syndrome
    Foundation for Fighting Blindness22 Nov 2021 - 31 Aug 2023
    Expired
  • GRANT
    Task Order #6: Assays for candidate AAV capsids
    Atsena Therapeutics8 Apr 2021 - 28 Feb 2022
    Expired
  • GRANT
    Quality Control ddPCR assay development
    Atsena Therapeutics28 Oct 2020 - 31 Oct 2022
    Expired
  • GRANT
    AAV-MEDIATED THERAPY FOR VISUAL IMPAIRMENT ASSOCIATED WITH FRIEDREICH'S ATAXIA
    Friedreichs Ataxia Research Alliance17 Sep 2020 - 30 Sep 2022
    Expired
  • GRANT
    Maintenance of mouse models of LCA1
    Atsena Therapeutics22 Jul 2020 - 30 Jun 2027
    Active
  • GRANT
    Task Order #2 - Dual AAV-MYO7A Candidate evaluation in Myo7a KO mice
    Atsena Therapeutics6 Jul 2020 - 30 Jun 2027
    Active
  • GRANT
    Task Order #1 - AAV-hRS1 Pharmacology
    Atsena Therapeutics2 Jul 2020 - 31 Aug 2022
    Expired
  • GRANT
    Nonhuman Primate Model of Usher Syndrome.
    Foundation for Fighting Blindness1 Jun 2020 - 31 May 2021
    Expired